The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, Dana-Farber Cancer Institute

Kenneth C. Anderson - Multiple myeloma cured in 2030: what are the next steps?Подробнее

Kenneth C. Anderson - Multiple myeloma cured in 2030: what are the next steps?

Updates on AL Amyloidosis Treatment: What is New in 2023 | Dana-Farber Cancer InstituteПодробнее

Updates on AL Amyloidosis Treatment: What is New in 2023 | Dana-Farber Cancer Institute

Multiple Myeloma Precursor Conditions | Overview | Therapeutic InterventionПодробнее

Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention

Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MDПодробнее

Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD

CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhDПодробнее

CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhD

Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MDПодробнее

Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MD

2019 Multiple Myeloma Symposium | Novel and Next Generation TherapyПодробнее

2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy

What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. RichardsonПодробнее

What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer InstituteПодробнее

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute

Bench to Bedside Immune Therapies in Multiple Myeloma | Ken AndersonПодробнее

Bench to Bedside Immune Therapies in Multiple Myeloma | Ken Anderson

Update on diagnosis and therapy of plasma cell dyscrasiasПодробнее

Update on diagnosis and therapy of plasma cell dyscrasias

Multiple Myeloma: Diagnosis and Risk Assessment | Dana-Farber Cancer InstituteПодробнее

Multiple Myeloma: Diagnosis and Risk Assessment | Dana-Farber Cancer Institute

Multiple Myeloma Symposium: Role of Integrative Therapies | Dana-Farber Cancer InstituteПодробнее

Multiple Myeloma Symposium: Role of Integrative Therapies | Dana-Farber Cancer Institute

Multiple Myeloma Symposium: Emerging Treatment Options | Dana-Farber Cancer InstituteПодробнее

Multiple Myeloma Symposium: Emerging Treatment Options | Dana-Farber Cancer Institute

Multiple Myeloma Symposium: Future of Treatment | Dana-Farber Cancer InstituteПодробнее

Multiple Myeloma Symposium: Future of Treatment | Dana-Farber Cancer Institute

Immunotherapy for Brain Cancer, with David ReardonПодробнее

Immunotherapy for Brain Cancer, with David Reardon

Новости